Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors.
Del Prete M, Di Sarno A, Modica R, Lassandro F, Giorgio A, Bianco A, Muto M, Gasperi M, Del Prete F, Colao A, Montesarchio V, Faggiano A; ENETS Centre of Excellence Multidisciplinary Group for Neuroendocrine Tumors in Naples (Italy).
Del Prete M, et al. Among authors: gasperi m.
J Endocrinol Invest. 2017 Dec;40(12):1373-1380. doi: 10.1007/s40618-017-0723-x. Epub 2017 Jun 30.
J Endocrinol Invest. 2017.
PMID: 28667452